Parma, Italy

Andrea Benassi

This inventor holds 3 USPTO granted patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2020-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Andrea Benassi: Innovator in Pharmaceutical Formulations

Introduction

Andrea Benassi is a notable inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of carrier particles for dry powder inhalation. With a total of 3 patents to his name, Benassi's work is paving the way for advancements in inhalation therapies.

Latest Patents

Benassi's latest patents include innovative solutions for dry powder formulations for inhalation. One of his key inventions focuses on carrier particles that enhance the delivery of high-strength dose active ingredients. This invention addresses the need for effective inhalation therapies, ensuring that patients receive the necessary medication in a more efficient manner.

Career Highlights

Andrea Benassi is currently employed at Chiesi Farmaceutici S.p.A., a leading pharmaceutical company known for its commitment to research and development. His work at Chiesi has allowed him to explore new frontiers in inhalation technology, contributing to the company's mission of improving patient outcomes.

Collaborations

Throughout his career, Benassi has collaborated with talented professionals in the field. Notable coworkers include Francesca Schiaretti and Ruggero Bettini, who have worked alongside him on various projects aimed at enhancing pharmaceutical formulations.

Conclusion

In summary, Andrea Benassi is a distinguished inventor whose work in dry powder formulations for inhalation is making a significant impact in the pharmaceutical industry. His innovative patents and collaborations reflect his dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…